Pricing Log in Create free account
Saturday 17 October 2026 Export TECH’s income statement to Excel — free account

Bio-Techne Corp

TECH Healthcare Biotechnology

Bio-Techne Corp’s revenue for fiscal 2026 (year ended June 2026) was $1.2 billion, roughly unchanged from fiscal 2025. In the quarter to June 2026, revenue grew 1.33%, EPS grew 418.2%, free cash flow fell 6.83% and total debt fell 42.2%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years.

72.54 0.02 +0.03%
Market cap
$11.4B
P/E
62.0×
Fwd P/E
37.6×
Dividend yield
0.44%
F-score
9/9
Altman Z
15.50
Beneish M
−2.52
Dividend safety
78/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Bio-Techne Corp (TECH) Operating margin

Alert me on Operating margin

Bio-Techne Corp's operating margin over the twelve months to 30 June 2026 was 20.7%. Over the past ten years it has ranged from 8.38% (fiscal 2025) to 32.5% (fiscal 2015); the current reading is higher than 33% of that period. That is above the Biotechnology industry median of 0.00% and above the Healthcare sector median of 0.00%.

Operating margin, annual

Embed this chart

Annual newest first

Period Operating margin Change (points)
FY2026 20.7% 12.35
FY2025 8.38% (9.45)
FY2024 17.8% (8.47)
FY2023 26.3% (0.53)
FY2022 26.8% 1.34
FY2021 25.5% 4.18
FY2020 21.3% 0.76
FY2019 20.6% (0.63)
FY2018 21.2% (0.24)
FY2017 21.4% (8.76)

Quarterly newest first

Period Operating margin Change (points)
Jun 2026 23.1% (1.11)
Mar 2026 24.2% 5.83
Dec 2025 18.4% 1.78
Sep 2025 16.6% 24.16
42 more quarters

Against its own ten years

Low 8.38% High 32.5%
Ten-year median 21.4%
Current reading's percentile 31

Operating margin against peers

Company Operating margin
KRYS Krystal Biotech, Inc. compare 44.9%
TECH Bio-Techne Corp 20.7%
BMRN BioMarin Pharmaceutical Inc. compare 4.38%
CORT Corcept Therapeutics Incorporated compare 0.77%
PCVX Vaxcyte, Inc. compare 0.00%
SMMT Summit Therapeutics PLC compare 0.00%
MDGL Madrigal Pharmaceuticals, Inc. compare −25.1%
BBIO BridgeBio Pharma, Inc. compare −69.8%
IBRX ImmunityBio, Inc. compare −151.9%
Biotechnology industry median 0.00%
Healthcare sector median 0.00%
Market median 0.00%

What Operating margin is

EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.

EBIT ÷ Revenue

The full definition of Operating margin →

More on TECH